Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma [Formula: see text].
Journal: Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
Published: July 27, 2016